(Reuters) – U.S.-German medical device maker Siemens Healthineers on Wednesday reported a 30% drop in quarterly operating profit, citing lower contributions from rapid COVID-19 antigen tests.
Adjusted earnings before interest and taxes (EBIT) fell to 681 million euros ($750 million) in the January-March period, less than the 702 million expected by analysts, according to a consensus provided by the company.
($1 = 0.9084 euros)
(Reporting by Bartosz Dabrowski in Gdansk; Editing by Miranda Murray)
